ArticleLancet regional health. Americas2021

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial.

Arturo Chang-Monteagudo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.